期刊文献+

5-氟尿嘧啶在结肠癌和肝癌细胞株诱导B7-H1的机制 被引量:3

The mechanism of 5-fluorouracil inducing BT-H1 in colon cancer and hepatoceUular carcinoma cell lines
原文传递
导出
摘要 目的探讨化疗药物5-氟尿嘧啶(5-Fu)在结肠癌细胞SW480和肝癌细胞HepG2对免疫共抑制分子B7-Ⅲ表达的诱导及机制。方法5-Fu处理细胞后24h用免疫荧光和流式细胞仪检测5-Fu对B7-H1蛋白表达的影响,在3~24h用荧光定量聚合酶链反应(RT-qPCR)检测其mRNA水平。结果5-Fu(10μg/L)处理这两种细胞24h后可探测出增强的B7-H1免疫荧光信号,流式细胞仪检测发现5-Fu处理SW480细胞后B7-H1蛋白含量为(14.88±1.43)%,处理HepG2细胞后B7-H1蛋白含量为(18.29±1.11)%,与各自对照组比较差异均有统计学意义(P〈0.05)。然而RT.qPCR检测表明在5.Fu处理后3~24h,SW480和HepG细胞内B7-H1mRNA的相对含量相对恒定。与各自对照组比较差异均无统计学意义(P〉0.05)。结论5-Fu在治疗肿瘤的同时会引起B7-Hl蛋白的表达,但这种增加与mRNA分子的转录无关。 Objective To study the mechanism of 5-fluorouracil (5-Fu) inducing B7-H1 in SW480 and HepG2 cells. Methods The B7-H1 protein expression was detected by using immunofluores- cence and flow cytometry in SW480 and HepG2 ceils at 24 h after 5-Fu treatment. The expression of B7-H1 mRNA was detected by using real-time quantitative polymerase chain reaction (RT-qPCR) 3-24 h after 5- Fu treatment. Results Immunofluorescence revealed a stronger fluorescence signal of B7-H1 in SW480 and HepG2 cells treated with 5-Fu ( 10 ixg/L) for 24 h. Flow cytometry demonstrated B7-H1 protein in SW480 ceils and HepG2 cells treated with 5-Fu treatment was ( 14. 88 -+ 1.43)% and ( 18. 29 + 1.11 )% respectively, which was significantly different from that in control group (P 〈 0. 05 ). Quantitative real-time PCR showed that the mRNA expression of B7-H1 was stable in SW480 and HepG2 cells 3-24 h after 5-Fu treatment. Conclusion 5-Fu could cause increased protein expression of B7-H1, which was not related with the increased mRNA expression.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第12期2498-2499,共2页 Chinese Journal of Experimental Surgery
基金 湖北省自然科学基金重点资助项目(2011CDA065)
关键词 结肠癌 肝细胞 5-氟尿嘧啶 B7-H1 Colon carcinoma Carcinoma, hepatocellular 5-fluorouracil B7-H1
  • 相关文献

参考文献3

二级参考文献7

共引文献26

同被引文献31

  • 1徐慧静,瞿青云.化疗泵阻塞原因分析及护理对策[J].临床护理杂志,2006,5(1):19-20. 被引量:2
  • 2杨文锋,于金明,左文述,王善政.食管癌组织中共刺激分子与白介素-10 mRNA的表达[J].中华肿瘤杂志,2006,28(10):762-765. 被引量:9
  • 3Jiang J,Wu C,Lu B.Cytokine-induced killer cells promote antitumor immunity[J].J Transl Med,2013,11:83-91.
  • 4Mesiano G,Todorovic M,Gammaitoni L,et al.Cytokine-induced killer(CIK)cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors[J].Expert Opin Biol Ther,2012,12:673-684.
  • 5Li XD,Ji M,Zheng X,et al.Evaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors[J].J Transl Med,2014,12:215-219.
  • 6Verma C,Eremin JM,Robins A,et al.Abnormal T regulatory cells(Tregs:FOXP3+,CTLA-4+),myeloid-derived suppressor cells(MDSCs:monocytic,granulocytic)and polarised T helper cell profiles(Th1,Th2,Th17)in women with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy(NAC)and surgery:failure of abolition of abnormal treg profile with treatment and correlation of treg levels with pathological response to NAC[J].J Transl Med,2013,11:11-16.
  • 7Wicherek L,Jozwicki W,Windorbska W,et al.Analysis of Treg cell population alterations in the peripheral blood of patients treated surgically for ovarian cancer-apreliminary report[J].Am J Reprod Immunol,2011,66:444-450.
  • 8苗培田.替吉奥联合伊立替康与替吉奥单药治疗晚期结肠癌的临床对照研究[J].医学信息,2015,33(45):89-89.
  • 9陈小林,区咏仪,李英儒,等.伊立替康治疗27例结肠癌肺转移的护理[J].中国保健营养(下旬刊),2013,23(11):6672-6673.
  • 10Ray PE,Al-Attar A,Liu XH,et al.Expression of a secreted fibroblast growth factor binding protein-1(FGFBP1)in angioproliferative kaposi sarcoma[J].J AIDS Clin Res,2014,5(6):309.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部